Cardiome Pharma Corp. (CRME) Posts Q1 Loss of 20c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
FMR LLC Raises Stake in Cardiome Pharma (CRME) to 10.05%
May 12, 2014 11:35 AM EDTIn a 13G filing on Cardiome Pharma (NASDAQ: CRME), hedge fund FMR LLC disclosed a 10.05%, or 1,654,012 share, stake in the company. This is up 439.80% from the 306,412 shares held at the end of the latest quarter.
For more notable holders of CARDIOME... More
